Showing results (51-60 of 108) with videos related to
Sort By:
Pageof 11
Journal of Clinical Microbiology|February 10, 2004
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida sppA Espinel-Ingroff, M Pfaller, S A Messer, et al.Diagnostic Microbiology and Infectious Disease|October 12, 2004
Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformansM A Pfaller, L Boyken, R J Hollis, et al.Journal of Clinical Microbiology|July 10, 2004
Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002M A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|March 7, 2006
In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillanceM A Pfaller, L Boyken, R J Hollis, et al.Journal of Clinical Microbiology|February 4, 2006
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida sppS A Messer, D J Diekema, L Boyken, et al.Journal of Clinical Microbiology|May 1, 2002
Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazoleM A Pfaller, D J Diekema, S A Messer, et al.Journal of Clinical Microbiology|January 9, 2003
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from bloodM A Pfaller, D J Diekema, S A Messer, et al.Infection Control and Hospital Epidemiology|June 5, 1998
Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unitS L Fowler, B Rhoton, S C Springer, et al.Journal of Clinical Microbiology|October 2, 2009
Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogensM A Pfaller, S A Messer, N Georgopapadakou, et al.Diagnostic Microbiology and Infectious Disease|February 20, 2004
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agentsM A Pfaller, D J Diekema, S A Messer, et al.Pageof 11